Guggenheim Capital LLC Novavax Inc Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Novavax Inc stock. As of the latest transaction made, Guggenheim Capital LLC holds 68,763 shares of NVAX stock, worth $582,422. This represents 0.01% of its overall portfolio holdings.

Number of Shares

68,763

Previous 55,404 24.11%

Holding current value

$582,422

Previous $701,000 23.82%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.71 - $17.11 $143,074 - $228,572	13,359 Added 24.11%	68,763 $868,000
Q2 2024 Aug 14, 2024	SELL	$3.89 - $20.97 $147,738 - $796,419	-37,979 Reduced 40.67%	55,404 $701,000
Q1 2024 May 14, 2024	BUY	$3.76 - $6.02 $35,283 - $56,491	9,384 Added 11.17%	93,383 $446,000
Q4 2023 Feb 14, 2024	BUY	$4.8 - $7.67 $63,484 - $101,443	13,226 Added 18.69%	83,999 $403,000
Q3 2023 Nov 14, 2023	SELL	$6.81 - $9.74 $66,935 - $95,734	-9,829 Reduced 12.19%	70,773 $512,000
Q2 2023 Aug 11, 2023	SELL	$6.67 - $9.52 $41,367 - $59,043	-6,202 Reduced 7.14%	80,602 $598,000
Q1 2023 May 10, 2023	BUY	$5.76 - $12.48 $166,907 - $361,632	28,977 Added 50.11%	86,804 $601,000
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $156,334 - $441,830	17,645 Added 43.91%	57,827 $594,000
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $34,270 - $143,333	1,883 Added 4.92%	40,182 $731,000
Q2 2022 Aug 15, 2022	BUY	$36.28 - $75.29 $345,458 - $716,911	9,522 Added 33.09%	38,299 $1.97 Million
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $570,182 - $1.17 Million	8,177 Added 39.69%	28,777 $2.12 Million
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $477,418 - $773,357	3,548 Added 20.81%	20,600 $2.95 Million
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $572,871 - $871,808	-3,222 Reduced 15.89%	17,052 $3.54 Million
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $182,226 - $388,051	1,506 Added 8.02%	20,274 $4.3 Million
Q1 2021 May 13, 2021	SELL	$112.98 - $319.93 $627,716 - $1.78 Million	-5,556 Reduced 22.84%	18,768 $3.4 Million
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $1.92 Million - $3.39 Million	24,324 New	24,324 $2.71 Million

Others Institutions Holding NVAX

# of Institutions

290

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Novavax Inc Transaction History